Viome
PrivateLast Round
Series D
Sep 10, 2024
Total Funding Raised
$281M
Company Overview
Viome is a biotechnology and wellness company that provides at-home health tests analyzing microbial and human gene expressions to offer personalized nutrition and supplement recommendations.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, D2C Brands, Subscription Commerce, Biotechnology, Medical AI
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viome Comps
Public and private peers based on sector, stage, and business model.
Viome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2024 | ||||
| Series C Extension | Aug 18, 2023 | ||||
| Series C | Oct 18, 2022 | ||||
| Convertible Debt | Nov 10, 2021 | ||||
| Debt | Feb 10, 2021 | ||||
Series B Extension | Apr 17, 2019 |
Viome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ocgrow Ventures | Convertible Debt, Series C |
| Glico | Convertible Debt, Series C |
| Khosla Ventures | Convertible Debt, Series D, Series B Extension, Series C, Series A, Series C Extension |
| WRG Ventures | Series D, Series C Extension |
| WestRiver Group | Convertible Debt, Series C |
| BOLD Capital Partners | Series A, Series C |
| Bold Capital | Convertible Debt, Series D, Series B Extension, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2025
Integration to leverage secure and scalable infrastructure services.
- Apr 14, 2025
Launched AI-powered RNA diagnostics for precision nutrition.
Viome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Viome's valuation, stock price, and market status.
